Novartis AG vs PulteGroup, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while PulteGroup, Inc. trades at $123.34 (market cap $23.46B). The key difference: Novartis AG is far larger — about 12.4× PulteGroup, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | PHM | |
|---|---|---|
Market Cap | $290.25B | $23.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $168.62 | $142.56 |
52-Week Low | $113.50 | $108.65 |
Enterprise Value | $330.27B | $23.42B |
Dividend Yield | 3.17% | 0.84% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →PulteGroup Inc is one of the largest homebuilders in the United States, operating in 40 markets across 23 states. The company mainly builds single-family detached homes (85% of unit sales) and offers products to entry-level, move-up, and active-adult buyers. PulteGroup offers homebuyers mortgage financing and title agency services through its financial services segment. The company is headquartered in Atlanta.
Read more on PHM →